Skip to main content may receive compensation from affiliate partners for some links on the site. Read our full Disclosure here.

Are the Experimental COVID-19 Jabs “Self-Spreading” Vaccines Transmitting to Unvaccinated People?


This may sound like something out of a science fiction novel, but it’s closer to reality than we can imagine.

Despite the legitimate concerns of the CCP developing bioweapons, there should be greater concern about potential bioweapons made here in the United States.

And that are potentially being used on the American population.

A new tool many scientists are experimenting with to vaccinate populations is self-spreading or “self-disseminating” vaccines.

If it sounds terrifying, that’s because it is.

Think of a virus or bacteria that’s highly transmissible in a population.

Now, imagine a vaccine that can do the same thing.

These genetically-engineered vaccines use the same mechanism to move through communities.

And they’re closer to reality than we think.

Children’s Health Defense shed light on “self-spreading” vaccines:

Although some of the uninjected tell pollsters they plan to eventually get the vaccine, a solid minority remains committed to never doing so. The same pattern appears to hold true globally: Roughly one-third of adults worldwide said they will not take a COVID shot.

While social and behavioral science researchers apply “soft science” techniques in an attempt to maneuver vaccine confidence into more acquiescent territory, bench scientists have a different option potentially waiting in the wings — genetically engineered vaccines that “move through populations in the same way as communicable diseases,” spreading on their own “from host to host.”

Not mainstream (yet)

In theory, self-spreading vaccines (also referred to as self-disseminating or autonomous) can be designed to be either transferable (“restricted to a single round of transmission”) or transmissible (“capable of indefinite transmission).”

Vaccine scientists concede transmissible vaccines “are still not mainstream, but the revolution in genome engineering poises them to become so.”

The makers of self-disseminating vaccines use recombinant vector technology to build genetic material from a target pathogen onto the “chassis” of a viral vector deemed “benign,” “innocuous” or “avirulent.” This is similar to the viral vector approach used to produce the Johnson & Johnson and AstraZeneca COVID vaccines.

For Johns Hopkins, the appeal of vaccines that are intentionally engineered to be self-disseminating seems obvious. The university’s Center for Health Security made its case explicit in a 2018 report, “Technologies to Address Global Catastrophic Biological Risks.” The report stated, “These vaccines could dramatically increase vaccine coverage in human …  populations without requiring each individual to be inoculated.”

Further spelling out the utilitarian implications of self-disseminating vaccines, the report’s authors stated, “only a small number of vaccinated individuals would be required to confer protection to a larger susceptible population, thus eliminating the need for mass vaccination operations.”

From a programmatic standpoint, this strategy would have the advantage of being “cheaper than vaccinating everyone by hand.” Perhaps even more significantly, however, it would override one of the “thorny ethical questions” that mass vaccination programs routinely wrestle with: informed consent.

As the university’s Center for Health Security briefly acknowledged in its report, self-disseminating vaccines would essentially make it impossible for “those to whom the vaccine subsequently spreads” to provide informed consent at all.

Before critics scream “Fake News,” let’s hear from Johns Hopkins themselves.

Here’s a piece from their 2018 “Technologies to Address Global Catastrophic Biological Risks” report:

Self-Spreading Vaccines: Selfspreading vaccines are genetically engineered to move through populations like communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in a target population could be vaccinated, and the vaccine strain would then circulate in the population much like a pathogenic virus, resulting in rapid, widespread immunity.

Ingestible Bacteria for Vaccination: Bacteria can be genetically engineered to produce antigens in a human
host, acting as a vaccine, which triggers immunity to pathogens of concern. These bacteria can be placed inside capsules that are temperature stable, and they can be self-administered in the event of a pandemic.

Self-Amplifying mRNA Vaccines: SAM vaccines use the genome of a modified virus with positive sense
RNA, which is recognizable to our human translational machinery. Once delivered inside a human cell, the SAM is translated and creates 2 proteins: an antigen of interest to stimulate an immune response, and a viral replicase for intracellular amplification of the vaccine. The ability of SAM to self-replicate results in a stronger, broader, and more effective humoral and cellular immune response than some other vaccines.

Also from the report:

What is the technology?

Self-spreading vaccines—also known as transmissible or self-propagating vaccines—are genetically engineered to move through populations in the same way as communicable diseases, but rather than causing disease, they confer protection. The vision is that a small number of individuals in the target population could be vaccinated, and the
vaccine strain would then circulate in the population much like a pathogenic virus. These vaccines could dramatically increase vaccine coverage in human or animal populations without requiring each individual to be inoculated. This technology is currently aimed primarily at animal populations. Because most infectious diseases are zoonotic, 40 controlling disease in animal populations would also reduce the risk to humans. There are 2 main types of self-spreading vaccines: recombinant vector vaccines and live viral vaccines. Recombinant vector vaccines combine the elements of a pathogenic virus that induce immunity (removing the portion that causes disease) with a
transmissible viral vector. Cytomegalovirus is one candidate vector for recombinant vaccines, because it is highly species-specific and moderately transmissible. Live viral vaccines are attenuated, meaning that the vaccine viruses are much less pathogenic than wild-type and would be similar to the oral polio vaccine or the live attenuated influenza vaccine (LAIV) in that those vaccines can sometimes transmit from person to person. Although there are substantial technical challenges in genetically engineering viruses, synthetic biology tools such as CRISPR/Cas9 are likely to aid researchers in overcoming these hurdles in the coming years. Self-spreading vaccines have already been used to protect wild rabbits from myxomatosis and to control Sin Nombre virus in rodent populations. Additional work is targeting Ebola virus in apes and bats, Lassa virus in rats, and bovine tuberculosis in badgers.

Here’s a key component that I want to emphasize:

While self-spreading vaccines could help reduce illness and death in a severe pandemic, this approach comes with several big challenges. One important component of the current vaccination approach for humans is the informed consent process. In order to receive a vaccine, individuals (or their legal guardians) must be informed about the risks of vaccination by a healthcare provider and provide their consent before being vaccinated. Those who decline are not forced to receive a vaccine. In the case of self-spreading vaccines, the individuals directly vaccinated would have this option, but those to whom the vaccine subsequently spreads would not. Additionally, self-spreading vaccines would potentially infect individuals with contraindications, such as allergies, that could be life-threatening. The ethical and regulatory challenges surrounding informed consent and prevention and monitoring of adverse events would be critical challenges to implementing this approach even in an extreme event. Finally, there is a not insignificant risk of the vaccine virus reverting to wild-type virulence, as has sometimes occurred with the oral polio vaccine—which is not intended to be fully virulent or transmissible, but which has reverted to become both neurovirulent and transmissible in rare instances. This is both a medical risk and a public perception risk; the possibility of vaccine-induced disease would be a major concern to the public. Modeling efforts suggest that making self-spreading vaccines weakly transmissible might reduce the risk of reversion to wild-type virulence by limiting
the number of opportunities for the virus to evolve. However, weakly transmissible vaccines would have
to be introduced to more people to obtain sufficient immunity in the target population.

Self-spreading vaccines eliminate your ability to receive informed consent and say no to a vaccine.

In essence, you get vaccinated from being in close proximity or making physical contact to someone who has received the injection.

And that leads me to my next question.

Could the experimental COVID-19 jabs be self-spreading vaccines that are transmissible in the population?

It’s not hard to conceive COVID-19 serving as their golden opportunity to roll out the technology on humans.

Now, I’m NOT asserting that they are “self-spreading” but merely raising the question.

One of the peculiar developments over the weekend was the Twitter suspension of Naomi Wolf:

Dr. Wolf has been one of the few people raising the important question of viral shedding.

There have been circulating reports of unvaccinated individuals developing health complications after long-term exposure to vaccinated individuals.

A common trend has been women developing irregular menstrual cycles:

Many women have shared their stories, but the mainstream press has been quick to cast viral shedding aside as a crackpot conspiracy:

But if viral shedding is such a conspiracy theory, why does the FDA have an entire document to study shedding from virus or bacteria-based gene therapies:

A link to the FDA document

What also stands out is Pfizer quietly mentioning that environmental exposure to the experimental jab can occur through inhalation or skin contact:

The document also discusses the potential of an adverse event following occupational exposure to the experimental jab via unplanned direct contact:

(Images sourced from The Daily Expose)

Notice that Pfizer uses the term “study intervention.”

By looking at the first page of the document, it’s clear that the study intervention is either the RNA-based COVID-19 vaccines or a placebo.

Don’t worry about authenticity, here’s the Pfizer document.

Scroll to Pages 67-69.

Tell us your thoughts.


Join the conversation!

Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!

We Love Trump
Thanks for sharing!
Send this to a friend